Alpha Tau Medical to Participate in Upcoming September Investor Conferences
JERUSALEM, August 30, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer...
Alpha Tau Medical to Participate in Upcoming September Investor Conferences
Alpha Tau Medical Announces Second Quarter 2022 - Financial Results and Provides Corporate Update
Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment Planning